Reported Standalone quarterly numbers for Vivimed Labs are:
Net Sales at Rs 53.12 crore in March 2022 up 53.19% from Rs. 34.68 crore in March 2021.
Story continues below Advertisement
Quarterly Net Loss at Rs. 18.60 crore in March 2022 up 40.66% from Rs. 31.35 crore in March 2021.
EBITDA stands negative at Rs. 1.12 crore in March 2022 up 93.95% from Rs. 18.51 crore in March 2021.
Vivimed Labs shares closed at 12.95 on June 06, 2022 (NSE) and has given -28.85% returns over the last 6 months and -56.54% over the last 12 months.
Story continues below Advertisement
| Vivimed Labs | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'22 | Dec'21 | Mar'21 | | Net Sales/Income from operations | 53.12 | 51.90 | 34.68 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 53.12 | 51.90 | 34.68 | | EXPENDITURE | | Consumption of Raw Materials | 31.12 | 38.22 | 13.28 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 1.20 | 0.49 | 4.87 | | Power & Fuel | -- | -- | -- | | Employees Cost | 8.58 | 8.07 | 9.87 | | Depreciation | 4.66 | 4.27 | 3.95 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 13.91 | 12.60 | 26.95 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -6.34 | -11.74 | -24.24 | | Other Income | 0.56 | -0.36 | 1.78 | | P/L Before Int., Excpt. Items & Tax | -5.78 | -12.10 | -22.46 | | Interest | 10.00 | 11.53 | 9.13 | | P/L Before Exceptional Items & Tax | -15.78 | -23.63 | -31.58 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -15.78 | -23.63 | -31.58 | | Tax | 2.82 | -- | -0.23 | | P/L After Tax from Ordinary Activities | -18.60 | -23.63 | -31.35 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -18.60 | -23.63 | -31.35 | | Equity Share Capital | 16.58 | 16.58 | 16.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.24 | -2.85 | -3.78 | | Diluted EPS | -2.18 | -2.77 | -3.67 | | EPS After Extra Ordinary | | Basic EPS | -2.24 | -2.85 | -3.78 | | Diluted EPS | -2.18 | -2.77 | -3.67 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
